• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY Back to Search Results
Model Number 180343
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dyspnea (1816); Pulmonary Edema (2020); Hypervolemia (2664)
Event Date 11/27/2021
Event Type  Injury  
Event Description
It was reported that a peritoneal dialysis (pd) patient had fluid around their lungs due to too much 1.5% solution.The patient was hospitalized and used a 1.5% and a 2.5% solution bag for treatment.The patient needed to order additional 2.5% solution bags to take fluid off and the clinic is aware.Per the pd nurse, the patient was not using the solution properly and has a mental illness causing the patient to be confused on how and what solutions to use.The patient has had some home visits and is being monitored.2.5% solution has been ordered.Upon follow-up, the patient¿s pd registered nurse (pdrn) confirmed the patient was hospitalized for dyspnea, fluid overload and pulmonary edema.It was reported the patient was utilizing only 1.5% dextrose-based solution, when the patient should have been using of 2.5% dextrose-based solution as trained.The pdrn confirmed the patient suffers from mental/behavioral health issues.The patient is forgetful and unintentionally non-compliant at times.The patient spent many years homeless, living under a bridge and received no medical or mental health care.The patient requires extra training and monitoring, which has been part of the plan-of-care since beginning renal replacement therapy (rrt).The patient received ccpd while hospitalized, utilizing a 2.5% delflex solution with good improvement of the patient¿s dyspnea, pulmonary edema, and fluid overload.The patient was discharged home on (b)(6) 2021, and resumed utilizing the same liberty select cycler as before the events.Per the pdrn, the events were unrelated to any fresenius product(s) and/or device(s) deficiency or malfunction.
 
Manufacturer Narrative
A temporal relationship exists between ccpd therapy utilizing the liberty select cycler, and the patient¿s serious adverse events of fluid overload (characterized by dyspnea), which progressed into pulmonary edema and required hospitalization.The patient¿s pdrn attributed causality to the patient¿s usage of 1.5% dextrose solution, when a 2.5% dextrose solution was needed to increase uf.The pdrn reported the events were unrelated to any fresenius product(s) and/or device(s) deficiency or malfunction.Pulmonary edema is a well-known potential complication of the esrd process and can be attributed to a wide-range of causes (e.G., non-compliance, physiological changes, mechanical issues, health status changes).Additionally, patient related factors such as non-compliance are significant contributing factors, limiting the efficacy of rrt.Based on the available information, the patient¿s liberty select cycler is disassociated from the events.There is no objective evidence indicating a serious injury, patient death, or other serious adverse event related to a fresenius device(s) or product(s) occurred warranting further investigation.Furthermore, the patient resumed utilizing the same liberty select cycler at home, without any reported issues of machine malfunction or deficiency.The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Event Description
It was reported that a peritoneal dialysis (pd) patient had fluid around their lungs due to too much 1.5% solution.The patient was hospitalized and used a 1.5% and a 2.5% solution bag for treatment.The patient needed to order additional 2.5% solution bags to take fluid off and the clinic is aware.Per the pd nurse, the patient was not using the solution properly and has a mental illness causing the patient to be confused on how and what solutions to use.The patient has had some home visits and is being monitored.2.5% solution has been ordered.Upon follow-up, the patient¿s pd registered nurse (pdrn) confirmed the patient was hospitalized for dyspnea, fluid overload and pulmonary edema.It was reported the patient was utilizing only 1.5% dextrose-based solution, when the patient should have been using of 2.5% dextrose-based solution as trained.The pdrn confirmed the patient suffers from mental/behavioral health issues.The patient is forgetful and unintentionally non-compliant at times.The patient spent many years homeless, living under a bridge and received no medical or mental health care.The patient requires extra training and monitoring, which has been part of the plan-of-care since beginning renal replacement therapy (rrt).The patient received ccpd while hospitalized, utilizing a 2.5% delflex solution with good improvement of the patient¿s dyspnea, pulmonary edema, and fluid overload.The patient was discharged home on (b)(6) 2021, and resumed utilizing the same liberty select cycler as before the events.Per the pdrn, the events were unrelated to any fresenius product(s) and/or device(s) deficiency or malfunction.
 
Manufacturer Narrative
Plant investigation: no parts were returned to the manufacturer for physical evaluation.A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformances, or any associated rework identified during the manufacturing process which could be related to the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The investigation into the cause of the reported problem was not able to be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIBERTY SELECT CYCLER ASSY(NON-VALUATED)
Type of Device
SYSTEM, PERITONEAL, AUTOMATIC DELIVERY
Manufacturer (Section D)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer (Section G)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer Contact
jason busch
920 winter st
waltham, MA 02451
9043166958
MDR Report Key13078928
MDR Text Key282733705
Report Number2937457-2021-02501
Device Sequence Number1
Product Code FKX
UDI-Device Identifier00840861102068
UDI-Public00840861102068
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181108
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,User Facility,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 01/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/23/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number180343
Device Catalogue NumberRTLR180343
Was Device Available for Evaluation? No
Device AgeMO
Date Manufacturer Received01/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/13/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
DELFLEX PD FLUID; DELFLEX PD FLUID; LIBERTY CYCLER SET; LIBERTY CYCLER SET
Patient Outcome(s) Hospitalization;
Patient Age68 YR
Patient SexFemale
Patient Weight64 KG
-
-